Who we are

Across all four sites, our leading neurologists have a neuroimmunological focus and are embedded in strong neuroscientific and immunological communities.  In addition, each site makes its own specific contributions to the initiative.  Leading the research at each of these sites are:

  • Rhine-Main Neuroscience Network: Stefan Bittner, Tobias Bopp, Sergiu Groppa, Helmut Jonuleit, Jonathan Kipnis, Detlef Schuppan,  Albrecht Stroh, Jacky Trotter, Ari Waisman, Nina Wettschureck and Frauke Zipp
  • Munich neuroimmunologists: Klaus Dornmair, Bernhard Hemmer, Reinhard Hohlfeld, Naoto Kawakami, Martin Kerschensteiner, Thomas Korn , Gurumoorthy Krishnamoorthy, Klaus Lehmann-Horn, Edgar Meinl and Mikael Simons
  • Münster Center: Thomas Budde, Catharina Groß, Luisa Klotz, Tanja Kuhlmann, Karin Loser, Sven Meuth, Hans-Christian Pape, Michael Schäfers, Nicholas Schwab, Lydia Sorokin, Heinz Wiendl and Alexander Zarbock
  • Bochum Center: Ralf Gold and Aiden Haghikia

Furthermore, there are three scientists associated to the network:

  • Associates: Gerd Meyer zu Hörste (Münster), Muthuraman Muthuraman (Rhine-Main Neuroscience Network), Anneli Peters (Munich)

News

Tue, 22/10/2019
The key lies in cell metabolism: Neuroscientist and neurologist Luisa Klotz wins renowned Heinrich-Pette-Award
Münster. For the third time the renowned neuroscience award “Heinrich Pette prize” goes to Münster, as this year Luisa Klotz was rewarded with the prestigious award for neuroscience researchers and clinicians at the congress of the German Society of Neurology in Stuttgart. Neurologist and Neuroscientist Luisa Klotz received the award for her outstanding research in […]...more
Mon, 07/10/2019
Talk “Der Einfluss der Ernährung und des Darms auf die Multiple Sklerose”
Muenster. The department of neurology with Institute of Translational Neurology warmly welcomes SFB 128-PI Prof. Aiden Haghikia, leading senior physician at the Department of Neurology at Bochum University Clinic. His talk “Der Einfluss der Ernährung und des Darms auf die Multiple Sklerose” provides insights into his latest research progress in this field. Time: Wednesday, October […]...more
Mon, 03/06/2019
Publication: Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects.
Muenster. For the first time scientists from the University of Münster could show that multiple sclerosis (MS) alters the energy metabolism of T cells during acute phases of disease exacerbation. Therapeutic interventions targeting the metabolism of activated T cells display new potential avenues for treatment of patients with MS affecting around 250,000 people in Germany. The […]...more